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Background: Recently a number of studies have documented the increasing use of both UM and contralateral prophylactic mastectomy (CPM) for the surgical treatment of unilateral ESBC, in women who are at average risk for developing a contralateral breast cancer (CBC) [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] .
Nation-wide studies demonstrated a 10% rise in UM rate and a150% rise CPM rates since 2000 across all age groups with unilateral ESBC 7, [9] [10] [11] 13 . There are no guidelines endorsing the use of CPM in non-high-risk women, because of a lack of survival benefit in this group 14 . While quantitative studies have demonstrated that more young, white, educated women of a higher socio-economic status are undergoing mastectomy; these studies do not describe why these women are choosing more extensive surgery 2, 7, 13, 15, 16 . Other studies have demonstrated that the surgeon may be an independent predictive factor for receiving mastectomy 1, 17 . To understand the decision-making process that results in women undergoing mastectomy(ies), we conducted a qualitative study exploring the perspectives of patients who chose UM +/-CPM and treating general surgeons. While quantitative studies have identified demographic and pathological factors associated with the increase in mastectomy this work moves to a deeper understanding of the patient's decision-making process resulting in the choice for mastectomy. Methods: Grounded theory (GT) methodology was used to generate a theoretical understanding of the choice for mastectomy [18] [19] [20] . Women who were suitable candidates for breast conserving therapy (BCT) but underwent UM +/-CPM were identified from 5 prospective databases at surgical centers in the Toronto Area, Canada. Participants were purposively sampled from these databases ensuring they varied in age, ethnicity and that comparable numbers of women who underwent UM and UM+CPM were recruited from each center. Breast surgeons from across Ontario, Canada and the United States were also purposively sampled ensuring that they varied in location of practice (academic and community, urban and non-urban) , length of practice, extent of training, and gender. GT methodology directed the generation of the interview guides, data collection and data analyis 19, 21, 22 . One-on-one interviews were audio-taped and performed by a single interviewer. Data collection continued until thematic saturation was achieved, as indicated by data redundancy 23, 24 . Constant comparative analysis allowed similar concepts to be grouped together into larger categories [19] [20] [21] . After analysis of the patient and surgeon interviews, triangulation across the data was completed allowing for the comparison and contrast of the concepts derived from across the patient and surgeon interviews 25 . Through constant comparative analysis it became apparent that the developing theory was reflective of the Health-Belief Model (HBM), a known conceptual framework that has been widely used and validated to explain health-related behaviours 26, 27 . The 4 concepts of the HBM are: 1. perceived susceptibility: the subjective perception of the risk of recurrence of the illness 28 , 2. perceived severity: the perception of the seriousness of leaving an illness untreated 29 , 3. perceived benefits: the perception that the behaviour is potentially beneficial in reducing the perceived susceptibility and/or severity 27, 28 , 4. perceived barriers: perception of the negative aspects related to undertaking the behaviour 27, 29 . Completing selective coding using the concepts of the health belief model, the triangulated data was iteratively explored and refined into larger themes driving the research toward theory construction. Theoretical coding resulted in theory generation which expands upon the health belief model, applying it to the understanding of the surgical decision-making process in ESBC. Results: Participants and Interviews: Interviews were conducted with 29 patients and 45 surgeons. Participant characteristics are included in Tables 1 and 2. 15 Table 3 . Some patients also discussed the benefit of avoiding future surveillance of the opposite breast and the additional benefit of symmetry and balance offered by having both breasts removed. Perceived Benefit -Surgeons: All of the surgeons described no significant decrease in either the susceptibility or severity of ESBC by undergoing UM+/-CPM. All surgeons reported describing no survival advantage offered by undergoing UM+/-CPM rather than BCT. "The long-term survival is no better with a mastectomy. I say, 'In other words, you're not going to live any longer if I remove your breasts. (Table 3) . Despite describing no substantial decrease in ipsilateral recurrence and CBC, nor notable survival advantage, surgeons recognized patients over-estimated the benefits of UM+/-CPM (Table 3) . 4. Perceived Barriers -Patients: Patients greatly underestimated the potential negative outcomes of undergoing more extensive surgery. Complications were often not attended to and very few reported considering the potential side-effects. "I was told that there is a chance after mastectomy that you could develop nerve pain. I minimized that part -I ignored it. That, of course, is what happened" (P4) ( Table 3 ). In contrast, many patients in our study reported suffering side-effects after undergoing a mastectomy. These included chronic nerve pain, changes in skin sensation and concerns with body image. While no patient described any difficulty in accessing a surgeon for the work-up and treatment of ESBC, some patients described receiving opposition from their surgeon about their surgical choice; particularly for those women who chose UM+CPM. "Actually, I wanted a prophylactic mastectomy as well. The surgeon really cautioned me against it; really didn't want me to do that at all. (P13) ( Table 3 ). Many women who had elected to undergo more extensive surgery described diminishing this barrier by finding support for this decision from friends, and family. Perceived BarriersSurgeons: While post-operative complications often went unconsidered by the patients, they were always routinely described by the surgeons as part of the surgical consultation, to ensure that patients were fully informed of both the risks and benefits. "You understand that 60% of women who get mastectomy will have chronic pain." (Table 3 ). In addition, surgeons often described encouraging women to undergo less extensive surgery, frequently recommending BCT. "I reiterate that the recommended procedure is to have the lumpectomy (ON-2) (Table 3) . Similarly, surgeons often discouraged women from undergoing UM+CPM, encouraging women to treat solely their current cancer. Discussion: Multiple studies have demonstrated that there is no difference in distant metastasis or survival when undergoing either BCT or UM [30] [31] [32] [33] . In average-risk women the risk of distant metastasis and death outweighs the risk of developing a CBC, negating the potential benefits of undergoing a CPM 34 . In contrast, undergoing CPM doubles the risk of post-operative mastectomy complications [35] [36] [37] . Given the potential for these complications and lack of survival benefit, it is not immediately apparent why women might choose to undergo UM+/-CPM. Applying the HBM demonstrates why the patients in our study decided to undergo mastectomy. The HBM states that a health-related behaviour is undertaken when the magnitude of the threat of the illness is weighed against the net benefits (and barriers) of undertaking that behaviour 28 . Patient's choice for mastectomy was based on their overwhelming perceptions about susceptibility to negative sequelae and severity of their ESBC. Women believed they were highly susceptible to ipsilateral recurrence, distant metastasis and development of a CBC. Patients perceived that the severity of ESBC was substantial, and that they had a high likelihood of dying from their disease. Women's perceptions were shaped by their previous cancer experiences, both by the difficulties some women encountered during their own diagnosis, as well as family and friends who had suffered recurrence, metastasis and/or death due to breast cancer. The over-estimation of the patients' perceived threat becomes apparent when contrasted with the information provided by the surgeons. Surgeons stated the risks of recurrence and CBC are low in average-risk ESBC, and that the local treatment of the primary tumour does not impact the development of a CBC or metastasis; countering patients' perceptions that remnant breast tissue leads to more extensive disease. Surgeons described the high survivability of ESBC rather than the high mortality, as perceived by the patients. HBM research has also demonstrated that the likelihood of engaging in a behaviour reflects the believed effectiveness of that behavior on reducing the perceived threat 26, 28, 38 . By choosing to undergo UM+/-CPM our patients believed they would eliminate all likelihood of recurrence, CBC, metastasis and subsequent death. Women who chose CPM also described the added benefits of avoiding surveillance in the contralateral breast, and improved symmetry. However, patients underestimated the costs/barriers of undergoing mastectomy(ies). While many of our patients suffered the complications of undergoing mastectomy(ies), none considered the potential for these complications in their decision-making process. In contrast, surgeons always described the potential complications of all the surgical options. We have demonstrated that the misperceived threat of ESBC is the driving factor behind women's choice for UM+/-CPM. Despite surgeons recommending BCT, patients chose to undergo UM+/-CPM. This discordance reflects patient's stronger weighting of information from treatment-related beliefs than the surgeon's evidence-based discussion. As the increasing rates of CPM have raised concerns about overtreatment, understanding the decision-making process for ESBC is important. This study provides an understanding as to why women are choosing to undergo UM+/-CPM and how we might improve upon the decision-making process. 
" (P16) • "The mammogram showed up nothing.. The MRI showed up a 3.75 centimeter tumour. It was very frustrating. I had the three months going back and forth to people trying to say that, 'There's something here'" (P26) • "In the MRI they found another mass in the other (the other) breast (which they missed before" (P27) • "She (my mother) died in 1984 of metastasized breast cancer to her liver" (P 27). • "She (my aunt) had a lumpectomy originally and the cancer came back."(P25). • "I spoke to friends of friends who were in the health care system, and I also spoke to other women who had, had breast cancer. The thing that stands out in my mind are the women who did not choose to have mastectomies who regretted the decisions later. I've spoken to quite a few people like that" (P9)
• 
"(ON-11) • "There is a 6-10% chance that you might get another breast cancer in that other breast in your lifetime. I think 90% chance that you won't get it sounds really high" (US-9) • "The risk for contralateral cancer. That risk is pretty much the same or just slightly higher than the average population risk. I quote 12-15% contralateral breast cancer to make them aware that the risk isn't that much higher on the other side." (US-14) • "The risk to you is not from having a new breast cancer. The risk to you is that the cancer you already have is spread." (US-18) • "We talk about the fact that people die from metastatic disease, and not from local recurrence of the breast" (ON-10) • "Removing the side has no relation to, you know, recurrence (locally or distally) of the side they've had treated They just don't want to hear the number."(ON-17). • "I can't get them beyond that differentiation local therapy and distant recurrence". (US-2) • "The most dangerous thing about breast cancer is if it spreads. So, what we do with the breast is not make the absolute determination of their prognosis. They have breast cancer already that may be a metastases that we are dealing with in the future rather than a tumour is the breast itself" (US-10)

(US-14)" • "My patient wants bilateral mastectomies, her mother had a mastectomy and radiation and then recurrence with metastasis and saw her have a terrible quality of life and die of the disease….In her mind those are really in the forefront" (ON-6) • "'I want a mastectomy'… Their mom died of breast cancer at 50 even though it's not high, high risk for them or something has happened to them in their life that has really freaked them out about breast cancer." (ON-17)
CONCEPT 3: PERCEIVED BENEFIT
Patients' Perception Of Benefit: Of Mastectomy
• Contralateral Prophylactic Mastectomy
• Survival Benefit 
• "I had already made up my mind to do the mastectomy because I don't want to live in the shadow of recurrence."(P7) • "I don't want any worries of recurrence. That's when I thought it is better just to remove it." (P6) • "By having a mastectomy suddenly I would reduce my chances of recurrence by 50%" (P4). • "I know that even if one cell is left there, it is a risk factor for recurrence" (P3) • "I thought, well if I have two mastectomies, there's no way I'm can ever get breast cancer again." (P2)
•
P13). • "I need to have it look symmetrical versus saving a breast for whatever have you. I knew that long-term I'd worry about cancer getting into my right breast." (P19) • "My choice would be flat (re CPM), because that also give me the peace of mind as well as the matching symmetry" (P14).
